Benzocaine 15 MG Oral Lozenge — RxCUI 199071
RxNorm drug concept · Semantic clinical drug
RxCUI 199071
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI199071
Official nameBenzocaine 15 MG Oral Lozenge
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Benzocaine 15 MG Oral Lozenge Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Benzocaine 15 MG Oral Lozenge
RxCUI 199071 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Benzocaine
1399IN
-
Benzocaine
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Bactimicina Sore Throat
1110709BN -
Chloraseptic
20772BN
-
Bactimicina Sore Throat
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Benzocaine Oral Lozenge
371020SCDF -
Benzocaine Lozenge Product
1295169SCDG -
Benzocaine Oral Product
1152969SCDG -
Benzocaine Oral Lozenge [Bactimicina Sore Throat]
1110711SBDF -
Benzocaine Oral Lozenge [Chloraseptic]
92145SBDF -
Bactimicina Sore Throat Lozenge Product
1296913SBDG -
Bactimicina Sore Throat Oral Product
1167292SBDG -
Chloraseptic Lozenge Product
1296126SBDG - +4 more in this family
-
Benzocaine Oral Lozenge
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Benzocaine 15 MG
315469SCDC -
Benzocaine 15 MG Oral Lozenge [Bactimicina Sore Throat]
1110712SBD -
Benzocaine 15 MG Oral Lozenge [Chloraseptic]
1245378SBD -
Benzocaine 15 MG [Bactimicina Sore Throat]
1110710SBDC -
Benzocaine 15 MG [Chloraseptic]
1245377SBDC
-
Benzocaine 15 MG
Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Benzocaine 15 MG
SCDC · 315469 -
Benzocaine Oral Lozenge
SCDF · 371020 -
Benzocaine Lozenge Product
SCDG · 1295169 -
Benzocaine Oral Product
SCDG · 1152969
Brand-Name Concepts
-
Benzocaine 15 MG Oral Lozenge [Bactimicina Sore Throat]
SBD · 1110712 -
Benzocaine 15 MG Oral Lozenge [Chloraseptic]
SBD · 1245378 -
Benzocaine 15 MG [Bactimicina Sore Throat]
SBDC · 1110710 -
Benzocaine 15 MG [Chloraseptic]
SBDC · 1245377 -
Benzocaine Oral Lozenge [Bactimicina Sore Throat]
SBDF · 1110711 -
Benzocaine Oral Lozenge [Chloraseptic]
SBDF · 92145 -
Bactimicina Sore Throat Lozenge Product
SBDG · 1296913 -
Bactimicina Sore Throat Oral Product
SBDG · 1167292 -
Chloraseptic Lozenge Product
SBDG · 1296126 -
Chloraseptic Oral Product
SBDG · 1169472
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 199071 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 24286-1577-01 | 3 BLISTER PACK in 1 BOX (24286-1577-1) / 6 LOZENGE in 1 BLI... | Bactimicina for Sore Throat | DLC Laboratories, Inc. | 2021-12-21 |
| 67172-0017-02 | 1 BLISTER PACK in 1 CARTON (67172-017-02) / 18 LOZENGE in 1... | Chloraseptic Warming Sore Throat | Prestige Brands Holdings, Inc. | 2012-01-01 |
| 67172-0018-02 | 1 BLISTER PACK in 1 CARTON (67172-018-02) / 18 LOZENGE in 1... | Chloraseptic Warming Sore Throat | Prestige Brands Holdings, Inc. | 2012-09-01 |
| 68229-0700-20 | 2 BLISTER PACK in 1 CARTON (68229-700-20) / 10 LOZENGE in 1... | CankerMelts | Quest Products, LLC | 2023-10-06 |
Observed labelers:
Prestige Brands Holdings, Inc. (2) ·
DLC Laboratories, Inc. (1) ·
Quest Products, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.